162 related articles for article (PubMed ID: 16182327)
1. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
[TBL] [Abstract][Full Text] [Related]
2. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
[TBL] [Abstract][Full Text] [Related]
3. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
[TBL] [Abstract][Full Text] [Related]
4. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991).
Beardow AW; Buchanan JW
J Am Vet Med Assoc; 1993 Oct; 203(7):1023-9. PubMed ID: 8135932
[TBL] [Abstract][Full Text] [Related]
5. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
[TBL] [Abstract][Full Text] [Related]
6. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
7. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
[TBL] [Abstract][Full Text] [Related]
8. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
[TBL] [Abstract][Full Text] [Related]
9. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation.
Tarnow I; Kristensen AT; Texel H; Olsen LH; Pedersen HD
J Vet Intern Med; 2003; 17(5):680-6. PubMed ID: 14529135
[TBL] [Abstract][Full Text] [Related]
10. Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation.
Moesgaard SG; Pedersen LG; Teerlink T; Häggström J; Pedersen HD
J Vet Intern Med; 2005; 19(5):712-9. PubMed ID: 16231716
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions.
Pedersen HD; Olsen LH; Mow T; Christensen NJ
Res Vet Sci; 1999 Feb; 66(1):11-7. PubMed ID: 10088706
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of plasma and urinary levels of 6-keto-prostaglandin F1alpha as a marker for asymptomatic myxomatous mitral valve disease in dogs.
Rasmussen CE; Sundqvist AV; Kjempff CT; Tarnow I; Kjelgaard-Hansen M; Kamstrup TS; Sterup AL; Soerensen TM; Olsen LH
Vet J; 2010 May; 184(2):241-6. PubMed ID: 19324577
[TBL] [Abstract][Full Text] [Related]
13. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
Busch M; Fleck C; Wolf G; Stein G
Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
[TBL] [Abstract][Full Text] [Related]
14. Dogs with heart diseases causing turbulent high-velocity blood flow have changes in platelet function and von Willebrand factor multimer distribution.
Tarnow I; Kristensen AT; Olsen LH; Falk T; Haubro L; Pedersen LG; Pedersen HD
J Vet Intern Med; 2005; 19(4):515-22. PubMed ID: 16095168
[TBL] [Abstract][Full Text] [Related]
15. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Elliott J
Am J Vet Res; 2012 Nov; 73(11):1765-74. PubMed ID: 23106462
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation.
Pedersen HD; Schütt T; Søndergaard R; Qvortrup K; Olsen LH; Kristensen AT
J Vet Intern Med; 2003; 17(2):178-84. PubMed ID: 12683618
[TBL] [Abstract][Full Text] [Related]
17. Intermittent mitral regurgitation in Cavalier King Charles spaniels: Short-term progression and influence of stress tests.
Reimann MJ; Møller JE; Häggström J; Åkerström LLB; Martinussen T; Olsen LH
Vet J; 2020 Apr; 258():105457. PubMed ID: 32564867
[TBL] [Abstract][Full Text] [Related]
18. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse.
Olsen LH; Kristensen AT; Häggström J; Jensen AL; Klitgaard B; Hansson H; Pedersen HD
J Vet Intern Med; 2001; 15(3):209-16. PubMed ID: 11380029
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of natriuretic peptides in dogs with mitral valve disease.
Tarnow I; Olsen LH; Kvart C; Hoglund K; Moesgaard SG; Kamstrup TS; Pedersen HD; Häggström J
Vet J; 2009 May; 180(2):195-201. PubMed ID: 18675567
[TBL] [Abstract][Full Text] [Related]
20. Hypomagnesemia and mitral valve prolapse in Cavalier King Charles spaniels.
Pedersen HD; Mow T
Zentralbl Veterinarmed A; 1998 Dec; 45(10):607-14. PubMed ID: 9923143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
